HUP9802447A3 - Piperazine derivatives process for their preparation and their use as 5-ht1a antagonists - Google Patents

Piperazine derivatives process for their preparation and their use as 5-ht1a antagonists

Info

Publication number
HUP9802447A3
HUP9802447A3 HU9802447A HUP9802447A HUP9802447A3 HU P9802447 A3 HUP9802447 A3 HU P9802447A3 HU 9802447 A HU9802447 A HU 9802447A HU P9802447 A HUP9802447 A HU P9802447A HU P9802447 A3 HUP9802447 A3 HU P9802447A3
Authority
HU
Hungary
Prior art keywords
preparation
piperazine derivatives
derivatives process
ht1a antagonists
ht1a
Prior art date
Application number
HU9802447A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HUP9802447A2 publication Critical patent/HUP9802447A2/hu
Publication of HUP9802447A3 publication Critical patent/HUP9802447A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9802447A 1995-07-20 1996-07-19 Piperazine derivatives process for their preparation and their use as 5-ht1a antagonists HUP9802447A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9514901.9A GB9514901D0 (en) 1995-07-20 1995-07-20 Piperazine derivatives

Publications (2)

Publication Number Publication Date
HUP9802447A2 HUP9802447A2 (hu) 1999-08-30
HUP9802447A3 true HUP9802447A3 (en) 1999-11-29

Family

ID=10778004

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802447A HUP9802447A3 (en) 1995-07-20 1996-07-19 Piperazine derivatives process for their preparation and their use as 5-ht1a antagonists

Country Status (21)

Country Link
EP (1) EP0839146B1 (hu)
JP (1) JP4166824B2 (hu)
KR (1) KR100447002B1 (hu)
CN (2) CN1077889C (hu)
AR (1) AR003451A1 (hu)
AT (1) ATE196294T1 (hu)
AU (1) AU700546B2 (hu)
BR (1) BR9609694A (hu)
CA (1) CA2227386C (hu)
DE (1) DE69610316T2 (hu)
DK (1) DK0839146T3 (hu)
ES (1) ES2150684T3 (hu)
GB (1) GB9514901D0 (hu)
GR (1) GR3034408T3 (hu)
HU (1) HUP9802447A3 (hu)
IL (1) IL122981A (hu)
MX (1) MX9800483A (hu)
NZ (1) NZ313231A (hu)
PT (1) PT839146E (hu)
WO (1) WO1997003982A1 (hu)
ZA (1) ZA966048B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
US20060287335A1 (en) 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US6469007B2 (en) * 2000-11-28 2002-10-22 Wyeth Serotonergic agents
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
KR20040105765A (ko) * 2002-03-12 2004-12-16 와이어쓰 키랄 ｎ-아릴 피페라진의 합성방법
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
JP2005527530A (ja) 2002-03-12 2005-09-15 ワイス キラル１，４−二置換ピペラジン
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
US6784294B2 (en) * 2002-03-12 2004-08-31 Wyeth Preparation of N1-(2′-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
PA8626301A1 (es) * 2004-03-19 2006-12-07 Wyeth Wyeth Proceso para preparar derivados de n-aril-piperazina
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
JP2008543867A (ja) 2005-06-17 2008-12-04 ワイス セロトニン阻害剤ならびに５−ｈｔ１ａアゴニストおよびアンタゴニストとして有用な三環系化合物
TW200808741A (en) * 2006-06-09 2008-02-16 Wyeth Corp 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
JPH10504275A (ja) * 1994-06-03 1998-04-28 ジョン・ワイス・アンド・ブラザー・リミテッド ピペラジン誘導体を製造するための新規な方法および中間体

Also Published As

Publication number Publication date
JP4166824B2 (ja) 2008-10-15
NZ313231A (en) 2001-03-30
DE69610316T2 (de) 2001-03-29
KR19990029067A (ko) 1999-04-15
EP0839146B1 (en) 2000-09-13
WO1997003982A1 (en) 1997-02-06
IL122981A0 (en) 1998-08-16
BR9609694A (pt) 1999-03-23
HUP9802447A2 (hu) 1999-08-30
GR3034408T3 (en) 2000-12-29
ES2150684T3 (es) 2000-12-01
AU6524996A (en) 1997-02-18
CN1309127A (zh) 2001-08-22
KR100447002B1 (ko) 2004-12-04
CA2227386A1 (en) 1997-02-06
CN1077889C (zh) 2002-01-16
ZA966048B (en) 1998-01-16
AU700546B2 (en) 1999-01-07
MX9800483A (es) 1998-04-30
PT839146E (pt) 2000-12-29
DK0839146T3 (da) 2000-11-20
IL122981A (en) 2001-01-28
CA2227386C (en) 2006-05-16
DE69610316D1 (de) 2000-10-19
GB9514901D0 (en) 1995-09-20
EP0839146A1 (en) 1998-05-06
AR003451A1 (es) 1998-08-05
JPH11509544A (ja) 1999-08-24
CN1131861C (zh) 2003-12-24
ATE196294T1 (de) 2000-09-15
CN1190968A (zh) 1998-08-19

Similar Documents

Publication Publication Date Title
AU2349395A (en) Morpholine derivatives and their use as antagonists of tachikinins
HUT76286A (en) Quinoline derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9904521A3 (en) Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
IL130297A0 (en) Sulphonamide derivatives process for their preparation and their use as medicaments
IL116518A0 (en) Piperazine derivatives pharmaceutical compositions containing them their use and processes for preparing them
HUP9800138A3 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use
AU4400796A (en) New piperazine derivatives and methods for the preparation thereof and compositions containing the same
HU9602305D0 (en) 4-heterocyclyl-substituted quinazoline derivatives, process for their preparation and their use as anti-cancer agents
IL125404A0 (en) 4-amino-pyrimidine derivatives medicaments containing these compounds their use and process for their production
IL118369A0 (en) Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HK1005801A1 (en) N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
HK1001618A1 (en) Novel pyrimidine derivatives and processes for the preparation thereof
HU9802653D0 (en) Substituted imidazolidine derivatives, process for producing them, their use, and pharmaceutical compositions containing them
HUP9802447A3 (en) Piperazine derivatives process for their preparation and their use as 5-ht1a antagonists
HUP0002718A3 (en) Piperazine derivatives, process for their preparation and medicaments containing the same
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
HUP9902091A3 (en) Indolealkyl derivatives of benzodioxanmethylamine and their use as 5-ht1a receptor ligands
CZ20012130A3 (cs) Piperazinový derivát, způsob jeho výroby a pouľití
HUP0002952A3 (en) Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them
HUT74187A (en) 3-phenyl-izoquinolin-(2h)-one derivatives, process for producing them and use of them for producing pharmaceutical compositions
EP0457155A3 (en) Carboxylate-ether derivatives of alkylmono- and alkylpolyglucosides, process for their preparation and their use
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
IL123900A0 (en) New phenylamidine derivatives processes for preparing them and their use as pharmaceutical compositions
HUP9902668A3 (en) Piperazine derivatives, pharmaceutical compositions containing them and their use
HUP0004648A3 (en) 3-substituted tetrahydropyridopyrimidinone derivatives and their use for producing pharmaceutical compositions

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees